Enoblituzumab Biosimilar - Research Grade
Product Specifications
Background
Uses the same sequence as the therapeutic antibody Enoblituzumab
Product Name Alternative
B7-H3, B7H3
Reactivity
Human
Target
CD276
Sequence
https://www.imgt.org/mAb-DB/
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
≥95% monomer by analytical SEC, >95% by SDS Page
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Fragment
Human IgG1 (K214R/L235V/ F243L/R292P/Y300L/P396L) -Kappa
Specificity
Detects human CD276
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO) : it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Human Angiopoietin-Like Protein 8/ANGPTL8/ betatrophin (N-Fc)
Tissue cDNA, First Strand, Human Adult Normal, Prostate, BioGenomicsTM
ITIH1 (IGHEP1, Inter-alpha-trypsin Inhibitor Heavy Chain H1, Inter-alpha-trypsin Inhibitor Complex Component III, Serum-derived Hyaluronan-associated Protein, MGC126415) (AP)
ITIH1 (IGHEP1, Inter-alpha-trypsin Inhibitor Heavy Chain H1, Inter-alpha-trypsin Inhibitor Complex Component III, Serum-derived Hyaluronan-associated Protein, MGC126415) (AP)
